Human gene therapy - JoVE Visualize

Showing results (2561-2570 of 4,125) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|February 3, 2005

Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survivalChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.

Human Gene Therapy|February 3, 2005

Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitutionMichael W Konstan, Pamela B Davis, Jeffrey S Wagener, et al.

Human Gene Therapy|February 1, 1992

Direct gene transfer into nonhuman primate myofibers in vivoS Jiao, P Williams, R K Berg, et al.

Human Gene Therapy|September 10, 2005

Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitisJustine R Smith, Claudie Verwaerde, Fabienne Rolling, et al.

Human Gene Therapy|September 10, 2005

Reversible mode of binding of serum proteins to DOTAP/cholesterol Lipoplexes: a possible explanation for intravenous lipofection efficiencyDmitri Simberg, Aryeh Weiss, Yechezkel Barenholz

Human Gene Therapy|March 12, 2005

Adenovirus vector-based vaccines for human immunodeficiency virus type 1Dan H Barouch, Gary J Nabel

Human Gene Therapy|March 12, 2005

Emergence of a scientific and commercial research and development infrastructure for human gene therapyChristine Crofts, Sheldon Krimsky

Human Gene Therapy|March 12, 2005

Inhibition of malignant glioma cell growth by a survivin mutant retrovirusA Temme, E Herzig, B Weigle, et al.

Human Gene Therapy|February 11, 2005

Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacyLucie Heinzerling, Günter Burg, Reinhard Dummer, et al.

Human Gene Therapy|February 11, 2005

Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type IIKerry O Cresawn, Thomas J Fraites, Clive Wasserfall, et al.

Pageof 413

Showing results (2561-2570 of 4,125) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|February 3, 2005

Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survivalChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.

Human Gene Therapy|February 3, 2005

Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitutionMichael W Konstan, Pamela B Davis, Jeffrey S Wagener, et al.

Human Gene Therapy|February 1, 1992

Direct gene transfer into nonhuman primate myofibers in vivoS Jiao, P Williams, R K Berg, et al.

Human Gene Therapy|September 10, 2005

Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitisJustine R Smith, Claudie Verwaerde, Fabienne Rolling, et al.

Human Gene Therapy|September 10, 2005

Reversible mode of binding of serum proteins to DOTAP/cholesterol Lipoplexes: a possible explanation for intravenous lipofection efficiencyDmitri Simberg, Aryeh Weiss, Yechezkel Barenholz

Human Gene Therapy|March 12, 2005

Adenovirus vector-based vaccines for human immunodeficiency virus type 1Dan H Barouch, Gary J Nabel

Human Gene Therapy|March 12, 2005

Emergence of a scientific and commercial research and development infrastructure for human gene therapyChristine Crofts, Sheldon Krimsky

Human Gene Therapy|March 12, 2005

Inhibition of malignant glioma cell growth by a survivin mutant retrovirusA Temme, E Herzig, B Weigle, et al.

Human Gene Therapy|February 11, 2005

Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacyLucie Heinzerling, Günter Burg, Reinhard Dummer, et al.

Human Gene Therapy|February 11, 2005

Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type IIKerry O Cresawn, Thomas J Fraites, Clive Wasserfall, et al.

Pageof 413